How big is the Global Point-of-Care Molecular Diagnostics Market?

The Global Point-of-Care Molecular Diagnostics Market size is expected to reach USD 3.67 billion in 2024 and grow at a CAGR of 8.77% to reach USD 5.57 billion by 2029. Read More

What is the current Global Point-of-Care Molecular Diagnostics Market size?

In 2024, the Global Point-of-Care Molecular Diagnostics Market size is expected to reach USD 3.67 billion. Read More

Who are the key players in Global Point-of-Care Molecular Diagnostics Market?

Abbott Laboratories, Danaher Corporation, BioMerieux, Bio-Rad Laboratories and F. Hoffmann-La Roche Ltd are the major companies operating in the Global Point-of-Care Molecular Diagnostics Market. Read More

Which is the fastest growing region in Global Point-of-Care Molecular Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Point-of-Care Molecular Diagnostics Market?

In 2024, the North America accounts for the largest market share in Global Point-of-Care Molecular Diagnostics Market. Read More

What years does this Global Point-of-Care Molecular Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Global Point-of-Care Molecular Diagnostics Market size was estimated at USD 3.37 billion. The report covers the Global Point-of-Care Molecular Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Point-of-Care Molecular Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Point-of-Care Molecular Diagnostics Companies

This report lists the top Global Point-of-Care Molecular Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Point-of-Care Molecular Diagnostics industry.